Bajaj Consumer Care Limited Overview
Bajaj Consumer Care is a mid-sized, debt-free Indian FMCG company whose economics are anchored in a single dominant franchise: Bajaj Almond Drops Hair Oil (ADHO), which commands an estimated 63%+ share of India's light hair oil (LHO) segment and is distributed through roughly 4.3 million retail outlets. Around ADHO the company has built adjacencies in coconut oil (Bajaj 100% Pure), ethnic/ayurvedic oils (Brahmi Amla, Amla Aloe Vera, Sarson Amla, Kailash Parbat), skin care (Nomarks), premium niche oils (Natyv Soul, 100% Pure range) and, since 2025, South Indian naturals via the Banjara's acquisition. After a decade of stagnant revenue (FY2021–FY2025) and a promoter-pledge overhang in 2019, BCCL entered a sharp operating upturn in FY2026—revenue crossed INR 1,000 Cr for the first time and gross margin expanded roughly 650 bps—driven by ADHO volume recovery, low-unit-pack expansion and the Project Aarohan route-to-market overhaul. Capital allocation favours tender-offer buybacks over dividends.
Company's own description
In its exchange filings, BCCL describes its single reportable segment as "Cosmetics, Toiletries and Other Personal Care Products" (NSE integrated filings, Q4 FY2025 and Q2 FY2026). The Business Responsibility & Sustainability Report (BRSR) for FY2026 describes the business as FMCG manufacturing, marketing and distribution of fast-moving consumer products, primarily hair care and other personal care products, and states that the company operates in hair care, hair styling and skin care categories. The FY2026 Annual Report (the company's 20th, themed "Shaping the Next Era of Growth") frames the strategy as strengthening the core personal care categories while extending that core into new consumer segments and need-states.
Independent characterisation
BCCL is best understood as a brand-owner and distribution company in the value-added hair oil (VAHO) category, with manufacturing as a supporting rather than defining capability. Its competitive moat rests on (i) the near-monopoly brand position of ADHO in light hair oils—a perfumed, non-sticky, almond-and-Vitamin-E positioned oil aimed historically at urban and semi-urban women; (ii) a general-trade distribution network covering several million outlets; and (iii) cost discipline that historically produced EBITDA margins near 20% on modest scale.
The structural weakness is concentration: hair and coconut oils accounted for approximately 98% of FY2026 standalone turnover (per BRSR-based reporting summarised by ScanX), and ADHO alone has historically represented the large majority of revenue (90%+ at the time of the 2010 IPO per CRISIL; the current ADHO share of revenue is not publicly disclosed). Diversification attempts (Nomarks from 2013, Natyv Soul, Almond Drops skin & hair, 100% Pure Coconut, Banjara's in 2025) have broadened the catalogue but have not yet materially diluted ADHO dependence.
Business and revenue model
| Dimension | Characterisation |
|---|---|
| Revenue model | ~100% product sales (FMCG goods); no service, subscription or licensing revenue of significance disclosed |
| Value chain position | Brand owner; procures raw materials (light liquid paraffin, refined/vegetable oils, copra, almond oil, fragrances, packaging); manufactures at two owned plants plus contract manufacturing units; sells via distributors to retailers |
| Customer types (direct) | Distributors/super-stockists (general trade), modern trade chains, e-commerce marketplaces and quick-commerce platforms, CSD (canteen stores), export distributors |
| End consumers | Indian households across urban and rural markets; core consumer historically women aged 15–45 in Hindi-speaking markets (HSM); Banjara's extends into South India |
| Channel mix | General trade dominant; organised trade (modern trade + e-commerce) growing. In Q1 FY2027 both general trade and organised trade grew in the "strong 20s" per the company's investor communication |
| Price architecture | Mass-premium within hair oils; increasing reliance on low-unit packs (LUPs) and sachets which grew faster than the brand average in Q1 and Q2 FY2027 |
| Geographic mix | ~97% domestic India; exports ~3% of standalone turnover to 35+ countries (BRSR FY2026), principally Nepal, Bangladesh, Middle East/GCC and Africa |
End-markets served
-
Light hair oil (LHO) — core; ADHO is category leader.
-
Coconut hair oil — the largest hair oil sub-category in India (≈47% of category value in 2025 per Ken Research), where BCCL is a challenger via Bajaj 100% Pure Coconut Oil and Bajaj Gold 100% Pure Coconut Oil.
-
Amla / ethnic / ayurvedic hair oils — Bajaj Brahmi Amla, Amla Aloe Vera, Sarson Amla, Amla Shikakai.
-
Cooling hair oils — Bajaj Kailash Parbat, Bajaj Cool Almond Drops.
-
Skin care — Nomarks (anti-marks creams/face care), Almond Drops body lotion and soap, Banjara's natural skin care (aloe vera gels, facial kits, herbal powders).
-
Hair care beyond oils — Almond Drops shampoo/conditioner/serum; Banjara's hair care powders and shampoos.
-
Premium natural oils — Natyv Soul and Bajaj 100% Pure (castor, olive, jojoba, kalonji, virgin coconut), largely digital/e-commerce led.
-
Oral care (legacy) — Bajaj Black Tooth Powder (historical; current scale not disclosed).
Strategy
Stated strategic themes (FY2026 Annual Report and recent earnings calls, paraphrased)
-
Strengthen and grow the core (ADHO) — sustain double-digit volume growth through price-point packs, sachets, distribution depth and consumer-metric improvement (penetration, brand health).
-
Extend the core into adjacent need-states — Almond Drops hair & skin care, coconut oils, ethnic oils, serums and styling.
-
Scale the non-ADHO portfolio, especially Banjara's (South India + HSM rollout) and Bajaj 100% Pure Coconut Oil.
-
Premiumisation — premium ADHO variants, Natyv Soul, 100% Pure specialty oils.
-
Route-to-market transformation (Project Aarohan) — expand direct reach roughly 10% per year for four to five years.
-
Revive international — new leadership and distributor model in Nepal, Bangladesh and MEA.
-
Calibrated innovation — management signalled "calibrated and spaced-out" innovations in specific opportunity areas rather than a scattershot launch pipeline (Q3 FY2026 call per ScanX).
-
Capital return — recurring tender buybacks rather than dividends.
Initiative register (last 24 months)
| Initiative | Launch / date | Scope | Targets / status |
|---|---|---|---|
| Project Aarohan 1.0 | Pilot Q1 FY2025 (UP, MP); scaled H2 FY2025–FY2026 | RTM redesign with a leading strategy consultant: move from sub-distributors to direct distributors in key towns, geo-tagging of all direct outlets (85%+ of urban outlets tagged), improved servicing of high-potential outlets | Expected ~1.4x improvement in urban outlet reach; achieved 100,000+ new outlets, 1,100+ distribution partners; ~670 vans closed; distribution expansion contributed ~2–3 pp to Q2 FY2027 volume growth |
| Project Aarohan 2.0 | Q2 FY2027 | Extend direct distribution ~10% in urban and >10% in rural markets across all 27 states | Medium-term target to lift direct distribution from ~50–60% of larger peers' level to ~75–80% |
| Banjara's integration | Feb 2025 onwards | Acquire, demerge operating undertaking into BCCL (effective 1 May 2026), extend into HSM, modern trade and exports | Integration declared complete in Q1 FY2027 |
| Price-point pack strategy | FY2026–FY2027 | Sachets and LUPs for ADHO | LUPs outperforming; key growth engine |
| Pricing actions | Q3 FY2027 (planned) | ~5% consumer price action (2–3% list price, rest via grammage) | To mitigate raw-material inflation |
| International reset | Mar 2026 | New Head of International (ROW, MEA & Nepal), distributor changes | Q1 FY2027 recovery |
| Digital media / e-commerce | Ongoing | Digital-first brands, connected TV ("TV dark market"), e-commerce ratings strategy | e.g., 9.7 mn reach / 20 mn views campaign (Q2 FY2025) |
| ESG: ZLD & ETP | FY2026 | Zero Liquid Discharge at Paonta Sahib; ETP upgrade at Guwahati | Completed per BRSR FY2026 |
| CSR: Miyawaki tree plantation | FY2025 | Urban forestry project | Reported in Q2 FY2025 presentation |
| Capital return | Jul 2024; Jul–Sep 2025 | Two tender buybacks at INR 290 | INR 166.5 Cr and INR 186.6 Cr executed |
Management guidance
BCCL does not issue formal numerical revenue or margin guidance. Qualitative guidance from recent calls: (i) targeting consistent double-digit growth over the long term (Q1 FY2027); (ii) A&P to be maintained around mid-teens % of revenue (14.6% in Q1 FY2027); (iii) inflationary pressure expected into Q2 and Q3 FY2027, with pricing to offset; (iv) ~10% annual expansion of direct coverage for four to five years (Q3 FY2026 call).
Products & Services
All products fall within the single segment. Pricing models are standard FMCG MRP-based retail pricing; specific price points are generally not disclosed in filings. Launch years are given where disclosed.
Almond Drops franchise (core)
| Product | Description / key attributes | Target customer | Launch / latest | Notes |
|---|---|---|---|---|
| Bajaj Almond Drops Hair Oil (ADHO) | Premium perfumed light, non-sticky hair oil positioned on almond oil and Vitamin E | Women 15–45, urban and rural, HSM core | Legacy (pre-2006 heritage); continuous pack renovations | Flagship; ~63%+ LHO share (SBI Securities); LUPs/sachets growing faster than brand average in FY2027 |
| ADHO low-unit packs & sachets | Affordable price-point packs; partial grammage reductions used as pricing lever | Rural and price-sensitive consumers | Ongoing; key growth engine in Q1–Q2 FY2027 | Underlying volume growth in early teens adjusted for pack-size reductions (Q1 FY2027) |
| Bajaj Cool Almond Drops Hair Oil | Cooling variant of ADHO | Summer/cooling-oil users | Disclosed in AR | Competes with Emami Navratna |
| Bajaj Almond Drops Almond Argan Hair Oil | ADHO with argan oil | Premium-seeking urban women | Disclosed in AR | Premiumisation variant |
| Bajaj Almond Drops Serum with Oil | Hair serum with almond oil | Urban, styling-oriented | Serum sachet launched Apr 2024 in West Bengal and Odisha GT | Hair styling entry |
| Bajaj Almond Drops Shampoo & Conditioner | Hair cleansing/conditioning regime | Existing ADHO users | Anti-Hairfall Shampoo launched c. FY2022 | Regime extension |
| Bajaj Almond Drops Moisturising Soap / Soap with Almond Oil | Bathing soap | Mass consumers | c. FY2021–FY2022 | Competes with HUL, Wipro, Godrej |
| Bajaj Almond Drops Nourishing Body Lotion | Lightweight almond-based body lotion | Urban women | Aug 2023 | Skin care extension |
| Bajaj Almond Drops Ultralight Body Lotion (Summer) | Aloe vera, almond oil, Vitamin E | Summer usage | Apr 2024 | Seasonal variant |
The Almond Drops Hair & Skin Care range (non-ADHO) grew ~33% in Q2 FY2025 per that quarter's earnings call and has strong e-commerce traction.
Coconut oil range
| Product | Description | Target | Launch | Notes |
|---|---|---|---|---|
| Bajaj 100% Pure Coconut Oil | Pure coconut oil, hair and edible-grade positioning | Mass households, HSM and Maharashtra | c. FY2021–FY2022 | Consistent share gains in several HSM states and Maharashtra (Q1 FY2025 presentation); 14% distribution increase in Q3 FY2025 |
| Bajaj Gold 100% Pure Coconut Oil | Premium/variant coconut oil | Value-premium | Q2 FY2025 | Disclosed in Q2 FY2025 presentation |
| Bajaj Coco Onion Non-Sticky Hair Oil | Coconut + onion, non-sticky | Hair-fall concerned consumers | c. FY2022 | Rides onion-oil trend |
| Bajaj Coco Jasmine Hair Oil | Coconut with jasmine fragrance | Mass | Disclosed in AR | Ethnic/perfumed coconut |
| Bajaj 100% Pure Virgin Coconut Oil | Cold-pressed virgin coconut | Premium, e-commerce | Disclosed in AR | Part of 100% Pure range |
Ethnic / ayurvedic range
| Product | Description | Notes |
|---|---|---|
| Bajaj Brahmi Amla Ayurvedic Hair Oil | Traditional heavy hair oil with brahmi and amla | Legacy brand |
| Bajaj Amla Aloe Vera Hair Oil | Amla with aloe vera | Launch disclosed in AR |
| Bajaj Sarson Amla Hair Oil | Mustard + amla | "New" in recent AR |
| Bajaj Amla Shikakai | Low-price amla variant | Price-conscious consumers |
| Bajaj Jasmine Hair Oil | Jasmine-perfumed hair oil | Legacy |
| Bajaj Kailash Parbat Cooling Oil | Ayurvedic cooling oil with sandal and almond extracts | Launched c. FY2013–FY2014 |
| Bajaj Zero Grey Hair Oil | Anti-greying positioning | Disclosed in AR |
| Bajaj Gulabjal | Rose water | Sales hit by planned market hygiene corrections in Q1 FY2025 |
| Bajaj 100% Pure Henna | Natural hair colour/conditioning | c. FY2022 |
Bajaj 100% Pure specialty oils
Castor Oil, Olive Oil, Jojoba Oil, Kalonji Oil, Virgin Coconut Oil — single-ingredient natural oils targeted at e-commerce and modern trade consumers seeking "clean" ingredients (FY2022 Annual Report).
Nomarks (skin care)
| Product | Description | Notes |
|---|---|---|
| Bajaj Nomarks creams | Ayurvedic anti-marks face creams | Acquired Aug 2013; 6.9% market share in its segment in 2015-16 (company history); relaunch in FY2019 with strongest share in Uttar Pradesh |
| Bajaj Nomarks Ayurveda range | Face washes and treatments | Current portfolio |
| Bajaj Nomarks Hand Sanitizer | Sanitizer | Launched 2020 (pandemic) |
Natyv Soul (premium, digital-first)
Natyv Soul Pure Argan Oil from Morocco; Natyv Soul Oil from Californian Almonds; Natyv Soul Hair Serum; Natyv Soul Hair Masque; hair oils with Marula Oil, Buriti Oil, Sacha Inchi Oil, Rosehip Oil and Apple Seed Oil (FY2022 Annual Report). Positioned as premium personal care for urban digital consumers; scale not disclosed.
Banjara's (acquired 2025)
| Product family | Description | Distribution |
|---|---|---|
| Facial kits | Herbal/natural facial kits | Cosmetic stores, pharmacies, supermarkets, grocery |
| Herbal powders | Multani mitti, herbal face/hair powders | 70,000+ outlets across five South Indian states at acquisition |
| Aloe vera gels | Skin and hair gels | Same |
| Shampoos and hair care powders | Natural hair care | Same |
| Hair oils | Natural hair oils | Same |
Founded 1991 in Hyderabad; revenue above INR 50 Cr with ~14% four-year CAGR at acquisition (Storyboard18). Strategy: deepen South India, introduce in HSM, scale in modern trade and exports. A dedicated Associate Vice President (Banjaras), Mallikeswaran, was appointed SMP from 3 March 2026.
Oral care (legacy)
Bajaj Black Tooth Powder — traditional tooth powder historically manufactured at Udaipur; current scale not disclosed.
Financial Narrative
Income statement (consolidated)
Sources: Net sales, operating profit, PBT, net income — Anand Rathi/CMOTS consolidated; FY2026 PBT and net income restated per Q2 FY2027 filing (INR 23,175.30 lakh and INR 19,056.48 lakh); as originally reported FY2026 PAT was INR 190.18 Cr. Gross profit, EBIT, EBITDA, EPS, A&P — S&P Global via StockAnalysis. DPS — Equitymaster/CMOTS.
Margin profile
Margins are computed on S&P standardised revenue; minor rounding differences versus company presentations exist. Note the low effective tax rate, reflecting area-based tax benefits at the Himachal Pradesh/Assam manufacturing locations and tax-efficient treasury income.
Revenue CAGR (analyst-computed): FY2022–FY2026 four-year CAGR 7.3%; FY2021 (net sales INR 921.81 Cr) to FY2026 five-year CAGR 4.8%. Net income five-year CAGR FY2021 (INR 223.13 Cr) to FY2026 is -3.1%; FY2021 remains the peak profit year owing to pandemic-era demand and very benign input costs.
Commentary. The five-year record divides into two eras. FY2021–FY2025 was a period of stagnation: net sales oscillated between INR 880 Cr and INR 984 Cr, while gross margin compressed from ~58% to ~54% as light liquid paraffin (a crude derivative) and vegetable oil prices spiked after 2021. Management responded by holding A&P at 15–18% of sales to defend ADHO share, which squeezed EBITDA margin to a trough of 12.7% in FY2025. FY2025 was additionally depressed by deliberate general-trade inventory "market hygiene" corrections in the first half (disclosed in Q1 and Q2 FY2025 earnings calls) as Project Aarohan restructured the distributor base.
FY2026 was the inflection. Net sales grew ~21% to INR 1,164.7 Cr; quarterly growth accelerated from low single digits organically in Q1 FY2026 to 32.7% in Q3 FY2026 and ~31% in Q4 FY2026. Gross margin expanded roughly 650 bps to ~60%, aided by softer paraffin and oil costs in the first nine months and by mix/pricing. EBITDA margin recovered to ~19% for the year and exited at 23.4% in Q4 FY2026. The Banjara's consolidation contributed roughly INR 60–80 Cr of incremental revenue (analyst estimate from subsidiary-level disclosures), meaning organic growth was still in the mid-teens.
Quarterly trajectory (consolidated)
Sources: Company results via Outlook Business, FPJ, Upstox, JM Financial, Arihant/CMOTS, Kotak Neo. Q4 FY2026 revenue is derived (FY2026 restated revenue INR 1,171.41 Cr minus Q1–Q3); Q4 FY2026 EBITDA derived from reported 23.4% margin; Q4 FY2026 PBT derived (FY2026 PBT minus Q1–Q3); Q1 FY2026 and Q4 FY2026 EPS analyst-computed. YoY growth for Q1–Q2 FY2026 computed against FY2025 quarters (Q1FY25 ~246, Q2FY25 ~234); Q2 FY2026 PAT growth versus INR 40.3 Cr (approx.). Note the Q1 FY2026 PAT appears as INR 37.93 Cr (as originally reported) and INR 38.28 Cr (restated).
H1 FY2027 (consolidated): revenue INR 674.40 Cr (+25%); net sales INR 674.1 Cr (+27.8%); EBITDA INR 167.6 Cr (+85%); PBT INR 174.0 Cr (+78.3%); PAT INR 140.9 Cr (+74.8%); operating cash flow INR 112.85 Cr (company results, 14 Oct 2026).
Q2 FY2027 cost detail: COGS INR 133.5 Cr (+26.8% YoY); employee costs INR 34.3 Cr (+0.3%); A&P INR 41.7 Cr (+7.2%); other expenses INR 40.0 Cr (+4.8%); D&A INR 3.8 Cr; finance cost INR 0.3 Cr. The near-flat A&P and employee lines against 25% revenue growth explain most of the margin expansion—operating leverage rather than gross margin, which actually declined sequentially (Q1 FY2027 gross margin 61.8% vs 63.0% in Q4 FY2026) as raw-material indices rose (light liquid paraffin index 152 vs 98 in Q4 FY2026; refined mustard oil 155 vs 138; copra 171 vs 149) (JM Financial summary of company disclosure).
Balance sheet (consolidated, year-end)
Source: S&P Global via StockAnalysis (converted from INR million). Debt consists entirely of lease liabilities; BCCL has no bank borrowings. Standalone net worth per BRSR FY2026 was INR 793.36 Cr; the gap to consolidated equity reflects acquisition accounting and subsidiary losses/eliminations.
Commentary. BCCL's balance sheet is conservatively, even excessively, liquid: treasury assets of INR 400–630 Cr represented 43–68% of total assets over the period. The decline in treasury from INR 629 Cr (FY2024) to INR 406 Cr (FY2026) is fully explained by three uses of cash—the July 2024 buyback (INR 166.5 Cr plus buyback tax), the September 2025 buyback (INR 186.6 Cr), and the Banjara's acquisition (cash acquisition outflow INR 62.4 Cr in FY2026 for the second tranche, with the first tranche paid in FY2025). The FY2026 jump in intangibles to INR 103.2 Cr reflects Banjara's brand recognition on consolidation. Receivables rose from 8 days of sales (FY2022) to 24–27 days (FY2025–FY2026), consistent with the shift toward modern trade, e-commerce and direct distributors under Aarohan.
Cash flow (consolidated)
Source: S&P Global via StockAnalysis. Company-reported FY2026 operating cash flow was INR 198.86 Cr (JM Financial); FY2026 buyback spend reported as INR 190.2 Cr (Indiantelevision). FY2025 OCF was depressed by a ~INR 28 Cr receivables build and Aarohan transition.
Commentary. The business is highly cash generative (FCF conversion of net income ~70–90% in normal years) and capital-light (capex under 1% of sales until FY2026). FY2026 capex rose to INR 32.8 Cr—the highest in the period—likely reflecting capacity/automation and environmental upgrades (ZLD at Paonta Sahib, ETP upgrade at Guwahati per BRSR), though the precise breakdown is not disclosed. BCCL has distributed more than 100% of FCF to shareholders in each of the last five years, drawing down the treasury corpus; this policy is not sustainable indefinitely at the FY2025 cash generation level, but is comfortably covered at the FY2026–FY2027 run-rate.
Ratios
Sources: ROE, ROA, ROIC, ROCE, current/quick ratios, D/E, net debt/EBITDA, asset and inventory turnover — S&P Global via StockAnalysis. Interest coverage and cash conversion cycle components are analyst-computed on year-end balances (interest is lease interest only, so coverage is not economically meaningful).
Commentary. ROIC (excluding the cash pile) is exceptional at 38–78%, illustrating a brand franchise that needs almost no operating capital. ROE is suppressed by surplus cash; the buybacks have been the lever to lift ROE from ~16% (FY2025) to ~25% (FY2026). The lengthening cash conversion cycle (19 to 42 days) is the most notable operating-quality watchpoint and reflects receivables growth and higher inventory ahead of price increases.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Net sales (INR Cr) | 879.96 | 960.87 | 984.12 | 964.83 | 1,164.71 |
Revenue growth YoY (%) | -4.5 | 9.2 | 2.4 | -2.0 | 20.7 |
Gross profit (INR Cr) | 509.3 | 519.2 | 540.0 | 522.3 | 705.0 |
Operating income — EBIT (INR Cr) | 169.4 | 133.1 | 145.5 | 117.7 | 205.6 |
EBITDA excl. other income (INR Cr) | 173.6 | 138.1 | 150.3 | 122.6 | 220.9 |
Operating profit incl. other income (INR Cr) | 212.55 | 178.28 | 199.97 | 162.98 | 248.05 |
Pre-tax income (INR Cr) | 206.47 | 168.79 | 189.04 | 152.29 | 231.75 |
Net income (INR Cr) | 169.63 | 139.22 | 155.43 | 125.26 | 190.56 |
EPS basic (INR) | 11.50 | 9.48 | 10.89 | 9.03 | 14.21 |
EPS diluted (INR) | 11.49 | 9.47 | 10.89 | 9.03 | 14.21 |
Dividend per share (INR) | 8.0 | 5.0 | 3.0 | 0 | 0 |
Advertising & promotion (INR Cr) | 147.7 | 174.5 | 162.2 | 141.3 | 173.8 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin (%) | 57.9 | 54.0 | 54.9 | 54.1 | 60.5 |
EBITDA margin (%) | 19.7 | 14.4 | 15.3 | 12.7 | 19.0 |
Operating (EBIT) margin (%) | 19.3 | 13.9 | 14.8 | 12.2 | 17.7 |
Pre-tax margin (%) | 23.5 | 17.6 | 19.2 | 15.8 | 19.9 |
Net margin (%) | 19.3 | 14.5 | 15.8 | 13.0 | 16.4 |
A&P as % of net sales (%) | 16.8 | 18.2 | 16.5 | 14.6 | 14.9 |
Effective tax rate (%) | 17.8 | 17.5 | 17.8 | 18.0 | 17.8 |
Income Statement and Margin Analysis (%) (Quarterly)
| Metric | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 | Q2FY27 |
|---|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 273.39 | 265.27 | 306.09 | 326.6 | 341.57 | 332.83 |
Revenue growth YoY (%) | 11.1 | 13.4 | 32.7 | 30.7 | 24.9 | 25.5 |
EBITDA (INR Cr) | 41.9 | 48.7 | 56.9 | 76.4 | 84.4 | 83.3 |
EBITDA margin (%) | 15.8 | 18.6 | 18.6 | 23.4 | 24.7 | 25.0 |
PBT (INR Cr) | 46.13 | 51.43 | 56.43 | 77.8 | 87.27 | 86.76 |
Net profit (INR Cr) | 38.28 | 42.29 | 46.37 | 63.63 | 70.75 | 70.15 |
PAT growth YoY (%) | 2.2 | 5.0 | 83.2 | 105.3 | 84.8 | 65.9 |
EPS (INR) | 2.79 | 3.24 | 3.44 | 4.87 | 5.42 | 5.37 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 931.5 | 924.4 | 983.6 | 901.1 | 945.1 |
Cash & equivalents (INR Cr) | 11.5 | 14.0 | 22.7 | 30.9 | 39.2 |
Cash + short-term investments + trading securities (INR Cr) | 623.4 | 591.1 | 629.1 | 452.1 | 406.1 |
Long-term investments (INR Cr) | 0 | 0 | 5.0 | 65.6 | 10.0 |
Short-term debt incl. current lease liabilities (INR Cr) | 0 | 3.2 | 4.8 | 2.5 | 4.3 |
Long-term debt incl. lease liabilities (INR Cr) | 0 | 6.1 | 4.0 | 1.7 | 11.5 |
Total debt (INR Cr) | 0 | 9.3 | 8.8 | 4.2 | 15.8 |
Net debt (INR Cr; negative = net cash) | -623.4 | -581.8 | -620.3 | -448.0 | -390.3 |
Shareholders' equity (INR Cr) | 809.6 | 789.7 | 830.6 | 747.9 | 755.0 |
Goodwill (INR Cr) | 43.0 | 43.0 | 43.0 | 43.0 | 43.0 |
Other intangibles (INR Cr) | 1.2 | 0.6 | 0.7 | 0.6 | 103.2 |
Goodwill & intangibles (INR Cr) | 44.2 | 43.6 | 43.7 | 43.6 | 146.2 |
Inventory (INR Cr) | 57.1 | 51.3 | 56.2 | 54.8 | 66.1 |
Receivables (INR Cr) | 19.4 | 30.8 | 44.3 | 71.9 | 75.6 |
Accounts payable (INR Cr) | 45.5 | 45.0 | 40.2 | 49.9 | 42.4 |
Working capital (INR Cr) | 628.8 | 606.5 | 647.8 | 507.2 | 433.5 |
Book value per share (INR) | 54.88 | 55.36 | 58.17 | 54.57 | 56.39 |
Cash Flow and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (INR Cr) | 128.5 | 101.5 | 116.3 | 65.1 | 196.9 |
Capital expenditure (INR Cr) | 10.7 | 6.4 | 4.3 | 5.4 | 32.8 |
Free cash flow (INR Cr) | 117.8 | 95.0 | 112.1 | 59.7 | 164.1 |
FCF margin (%) | 13.4 | 9.9 | 11.4 | 6.2 | 14.1 |
Cash acquisitions (INR Cr) | 0 | 0 | 0 | 0 | 62.4 |
Dividends paid (INR Cr) | 118.0 | 59.0 | 114.1 | 0 | 0 |
Share buybacks (INR Cr) | 0 | 100.2 | 0.6 | 206.2 | 190.2 |
Total shareholder distributions (INR Cr) | 118.0 | 159.2 | 114.7 | 206.2 | 190.2 |
Distributions as % of FCF (%) | 100 | 168 | 102 | 345 | 116 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%) | 21.7 | 17.4 | 19.2 | 15.9 | 25.3 |
ROA (%) | 11.6 | 9.0 | 9.5 | 7.8 | 14.0 |
ROIC (%) | 77.9 | 55.7 | 57.2 | 37.8 | 50.9 |
ROCE (%) | 20.8 | 16.6 | 17.3 | 15.6 | 26.7 |
Current ratio (x) | 6.32 | 5.86 | 5.49 | 4.48 | 3.49 |
Quick ratio (x) | 5.44 | 4.98 | 4.67 | 3.60 | 2.77 |
Debt / equity (x) | 0 | 0.01 | 0.01 | 0.01 | 0.02 |
Net debt / EBITDA (x) | -3.59 | -4.21 | -4.13 | -3.65 | -1.81 |
Interest coverage EBIT / interest (x) | 194 | 137 | 143 | 219 | 128 |
Asset turnover (x) | 0.96 | 1.03 | 1.03 | 1.02 | 1.26 |
Inventory turnover (x) | 7.39 | 8.15 | 8.26 | 7.98 | 7.64 |
Days sales outstanding (days) | 8.0 | 11.7 | 16.4 | 27.2 | 23.7 |
Days inventory outstanding (days) | 56.2 | 42.4 | 46.2 | 45.2 | 52.5 |
Days payables outstanding (days) | 44.8 | 37.2 | 33.0 | 41.2 | 33.7 |
Cash conversion cycle (days) | 19.4 | 16.9 | 29.6 | 31.2 | 42.5 |
Geography Overview
| Geography | FY2026 |
|---|---|
India — share of standalone turnover (%) | 97 |
International — share of standalone turnover (%) | 3 |
Region / Country Details
| Region / country | Recent trend | Reason | Source |
|---|---|---|---|
Bangladesh | +103% YoY in Q2 FY2025; weakness in FY2026; double-digit growth in Q1 FY2027 | Transition from national distributor to own distribution (completed Q1 FY2025); political disruption in 2024–2025; recovery on low base | Q1/Q2 FY2025 calls; Q1 FY2027 results |
Nepal | Challenged in FY2026; double-digit growth in Q1 FY2027 | Distribution partner changes and new leadership | FY2026 commentary; Q1 FY2027 results |
UAE / MEA | Expansion to 100+ stores in UAE (Q1 FY2025); "West Asia crisis" disruptions cited in Q1 FY2027 | Geopolitical disruption | Q1 FY2025 call; Q1 FY2027 presentation |
International overall | Mid-single-digit decline YoY in Q3 FY2026; "strong comeback" in Q1 FY2027 after leadership and distribution partnership changes | New Head of International Business (ROW, MEA & Nepal) from 1 Mar 2026 | Q3 FY2026 call; Kotak Neo |
Share Price & Returns
| Reference point | Price | Return to INR 479.10 (15 Oct 2026) |
|---|---|---|
Oct 2021 month-end (unadjusted) | 231.30 | ~107% (5-year, price only) |
Oct 2023 month-end (unadjusted) | 232.30 | ~106% (3-year) |
Oct 2025 month-end | 276.65 | ~73% (1-year) |
52-week high | 691.15 | -31% |
52-week low | 220.05 | +118% |
Share Price and Market Valuation
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Year-end share price (INR, adjusted) | 153.43 | 146.39 | 212.10 | 157.25 | 347.00 |
Market capitalisation (INR Cr) | 2,409 | 2,167 | 3,025 | 2,245 | 4,533 |
Enterprise value (INR Cr) | 1,818 | 1,548 | 2,453 | 1,820 | 4,263 |
P/E (x) | 14.2 | 15.6 | 19.5 | 17.9 | 23.8 |
EV/EBITDA (x) | 10.5 | 11.2 | 16.3 | 14.9 | 19.8 |
EV/Sales (x) | 2.07 | 1.61 | 2.49 | 1.89 | 3.66 |
P/B (x) | 2.98 | 2.74 | 3.64 | 3.00 | 6.00 |
Dividend per share (INR) | 8.0 | 5.0 | 3.0 | 0 | 0 |
Buyback yield (%) | 0 | 0.4 | 2.9 | 2.8 | 3.6 |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
Market cap | ~INR 6,258 Cr | 130.62 mn shares |
Enterprise value | ~INR 5,868 Cr | Less FY2026 net cash INR 390 Cr |
P/E (TTM) | ~25.1x | TTM EPS ~INR 19.10 (Q3 FY2026–Q2 FY2027) |
EV/EBITDA (TTM) | ~19.5x | TTM EBITDA ~INR 301 Cr |
EV/Sales (TTM) | ~4.5x | TTM revenue ~INR 1,307 Cr |
P/B | ~8.3x | FY2026 consolidated equity INR 755 Cr |
Analyst Ratings & Targets
| Broker | Date | Rating | Target (INR) |
|---|---|---|---|
Choice Institutional Equities | 15 Oct 2026 | BUY (DCF-based) | 715 |
SBI Securities | — | "Pick of the Week" | — |
Consensus | — | Not reliably available | An aggregator-cited "consensus INR 279" from five analysts is clearly stale (pre-rerating) and disregarded |
Dividend History
| FY | DPS (INR) | Type | Payout ratio (%) |
|---|---|---|---|
FY2020 | 2.0 | Final | 16 |
FY2021 | 10.0 | Final/interim | 66 |
FY2022 | 8.0 | Interim INR 4 + Final INR 4 | 70 |
FY2023 | 5.0 | Final | 51 |
FY2024 | 3.0 | Interim (Feb 2024) | 28 |
FY2025 | 0 | — | 0 |
FY2026 | 0 | — | 0 |
Share Price & Returns — 2020
| Year | Route | Size (INR Cr) | Price (INR) | Shares |
|---|---|---|---|---|
| 2020 | Open market | — | — | — |
2022 (FY2023) | — | ~100 | — | — |
| 2024 | Tender | 166.49 | 290 | ~5.74 mn |
| 2025 | Tender | 186.60 | 290 | 6.43 mn |
Analyst Conclusions
Management guidance
No numerical guidance. Management targets consistent double-digit growth over the long term, expects input-cost inflation through Q2–Q3 FY2027, plans ~5% consumer price action in Q3 FY2027, and intends ~10% annual expansion in direct reach (Aarohan 2.0). A&P is expected to stay near mid-teens % of revenue.
Consensus growth expectations
Not reliably available. Choice Institutional Equities' BUY/INR 715 call implies expectations of sustained mid-teens-plus earnings growth; S&P's forward P/E of ~23x at INR 483 implies forward EPS near INR 21 (analyst inference from S&P forward P/E).
Bull case (three arguments)
-
The volume engine is real, not just pricing. ADHO delivered >30% domestic revenue growth in Q1 and Q2 FY2027 with double-digit unit volumes, while distribution contributed only 2–3 pp — meaning brand pull and LUP penetration are doing the heavy lifting. If Aarohan 2.0 lifts direct reach toward 75–80% of peer levels, there is multi-year volume runway.
-
Operating leverage on a fixed cost base. Employee and other expenses grew 0–5% in Q2 FY2027 against 25% revenue growth; EBITDA margin reached 25.0%. Even with gross margin pressure, each incremental INR 100 Cr of revenue at ~60% gross margin drops disproportionately to EBITDA.
-
Capital allocation optionality. With ~INR 390 Cr net cash, ~INR 160–200 Cr annual FCF and no debt, BCCL can continue buybacks (~3–4% annual yield) and still fund bolt-on acquisitions like Banjara's, compounding EPS faster than net income.
Bear case (three arguments)
-
Margin peak risk. Light liquid paraffin index rose from 98 to 152 within two quarters; gross margin already slipped from 63.0% (Q4 FY2026) to 61.8% (Q1 FY2027). FY2021–FY2025 showed how quickly input inflation can compress EBITDA margin from ~20% to ~13%.
-
Base effects and growth normalisation. FY2026's 21% growth and H1 FY2027's 25% growth lap a weak FY2025 base (which included distributor inventory corrections); from H2 FY2027 the comparison base is far tougher (Q3–Q4 FY2026 grew 31–33%).
-
Concentration and execution risk. ~98% of revenue from oils, heavy management turnover (MD, finance, strategy, marketing, CS, internal audit within ~13 months), and a history of adjacencies not scaling suggest the portfolio diversification thesis remains unproven.
Key catalysts and monitorables (next 12 months)
| Monitorable | Why it matters | Timing |
|---|---|---|
| Q3 FY2027 results (likely Jan 2027) | First quarter against a 32.7% growth base; impact of ~5% price/grammage action on volume | Jan 2027 |
| Gross margin trajectory vs LLP/copra/mustard indices | Determines whether 24–25% EBITDA margin holds | Quarterly |
| Aarohan 2.0 metrics (outlets, distributors, rural reach) | Validates volume runway | Quarterly calls |
| Banjara's HSM rollout and revenue disclosure | Tests diversification thesis | FY2027–FY2028 |
| International (Nepal, Bangladesh, MEA) | Recovery sustainability under new leadership | Quarterly |
| Capital return announcement | Third buyback or dividend reinstatement | Typically July board meetings |
| Management stability | Filling CMO and internal audit roles; board refresh | Ongoing |
| Competitive activity in LHO/serums | Share defence | Ongoing |
Analyst verdict
Bajaj Consumer Care has executed one of the sharpest operating turnarounds in Indian mid-cap FMCG over the past eighteen months. After four years in which revenue went nowhere and EBITDA margins halved, FY2026 delivered ~21% revenue growth, ~650 bps of gross margin expansion and a 52% jump in profit; H1 FY2027 accelerated further, with EBITDA up 85% and margins at a record ~25%. Crucially, the growth is volume-led — ADHO unit volumes are growing at double digits — and is supported by a credible, measurable distribution programme (Aarohan) rather than one-off pricing.
The franchise economics are outstanding: a near-monopoly in light hair oils, ROIC above 50%, minimal capex needs, and a debt-free balance sheet that funds both bolt-on M&A and recurring buybacks. At ~25x TTM earnings and ~19–20x TTM EV/EBITDA after the 15 October sell-off, the stock trades at a discount to large-cap HPC peers despite superior near-term growth.
The risks, however, are concentrated and well-known. BCCL is still effectively a one-brand, one-category company whose margins are hostage to crude-linked paraffin and vegetable-oil prices — and those indices have turned sharply upward. The second half of FY2027 laps a demanding 31–33% growth base, and management continuity has been poor, with nearly every senior function changing hands since mid-2025. The diversification story (Banjara's, coconut, skin care) is promising but unproven at scale.
On balance, the evidence supports a constructive but margin-sensitive view: the structural improvements in distribution and volume are durable, but investors should underwrite normalised EBITDA margins closer to 20–22% rather than the 25% peak, and look to Q3 FY2027 volume data after the planned price/grammage action as the decisive test. Execution on Aarohan 2.0 and stable leadership are the factors most likely to determine whether the 2026 re-rating proves sustainable.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Since | Background / notes |
|---|---|---|---|
Kushagra Nayan Bajaj | Non-Executive Chairman | Long-standing (Chairman since at least 2014) | Promoter; also Chairman & MD of Bajaj Hindusthan Sugar Ltd; DIN 00017575 |
Naveen Pandey | Managing Director | 1 Jul 2025 (5-year term to 30 Jun 2030) | 20+ years leadership experience across P&L, strategy, innovation, sales, marketing, investor and regulatory affairs; 5+ years in general management including ~2 years as MD of a listed company (per board outcome filing, 24 Jun 2025); DIN 09584377 |
Aakash Gupta | Head-Finance (Senior Management Personnel) | 1 Jul 2025 | Replaced Richard D'Souza (resigned) |
Jignesh Nagda | Company Secretary | Appointed 13 Jul 2026 | Succeeds Vivek Mishra (previously Head-Legal & Company Secretary) |
Mallikeswaran | Associate Vice President (Banjaras), SMP | 3 Mar 2026 | Leads acquired business |
| — | Head — International Business (ROW, MEA & Nepal), SMP | 1 Mar 2026 | Appointed after Deepak Himan's exit |
Deepak Himan | Former Head-Strategy & International Business | Resigned 1 Jan 2026; relieved 28 Feb 2026 | Departure |
Sanath R Pulikkal | Former Chief Marketing Officer | Joined Jun 2024; exited Apr 2026 | Per exchange4media, 17 Apr 2026 |
Harshit Shah | Former Head-Internal Audit | Resignation announced 2026 | Per ScanX |
| — | Senior management personnel with prior experience at Bharti Tele-Ventures and UB Group | Resigned; cessation 31 Mar 2026 | NSE filing, 22 Dec 2025 |
Board of Directors
| Director | Category | Notes |
|---|---|---|
Kushagra Nayan Bajaj | Non-Executive Chairman, Promoter | Retires by rotation periodically |
Naveen Pandey | Managing Director (Executive) | From 1 Jul 2025 |
Sumit Malhotra | Non-Executive, Non-Independent | Former MD |
Apoorv Bajaj | Non-Executive, Non-Independent (promoter relative) | — |
Jagdish Acharya | Independent | Chaired 2024 AGM in Chairman's absence |
Anupam Dutta | Independent | Present at 2024 AGM |
Lilian Jessie Paul | Independent | Appointed 2019 |
Jitendra Ananda Mahajan | Independent (Additional Director) | Appointed 14 Oct 2026 for five years, subject to shareholder approval |
| — | Independent | Resigned effective 14 Oct 2026 citing personal medical reasons and professional commitments |
Two further independent directors | Independent | — |
Shareholding Trend
| Holder category | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
Promoters (%) | 40.95 | 40.95 | 42.97 | 42.97 | 42.96 |
Foreign institutions (%) | 10.95 | 10.12 | 9.70 | 16.59 | 16.1 |
Mutual funds (%) | 16.32 | 14.61 | 15.02 | 13.41 | not disaggregated |
Other domestic institutions (%) | 0.50 | 0.66 | 0.72 | 0.86 | 0.8 |
Retail and others (%) | 31.27 | 33.66 | 31.59 | 26.17 | 26.0 |
Competitive Landscape
Competitors by Segment
| Category | Competitor | Key brands | Positioning vs BCCL |
|---|---|---|---|
Light hair oil | Marico | Hair & Care, Shanti Badam Amla (historical LHO challenger), Hair & Care Oil in Serum (Aug 2024) | Largest VAHO player overall; main LHO challenger |
Light/almond oils | Dabur India | Dabur Almond Hair Oil, Vatika | Strong in amla; almond variants compete directly |
Coconut oil | Marico | Parachute (~57% coconut oil share, dated) | Dominant; BCCL is a small challenger |
Amla / ayurvedic oils | Dabur India | Dabur Amla | Category leader in amla |
Cooling oils | Emami | Navratna (leader in cooling oil, ~55% share historically) | Competes with Kailash Parbat, Cool Almond Drops |
Therapeutic hair oils | Emami | Kesh King | Adjacent |
Mass hair care / ayurvedic | Hindustan Unilever | Indulekha, Clinic Plus, Dove (Dove Elixir hair oil historically) | Scale and distribution advantage |
Ayurvedic / naturals | Patanjali Ayurved | Kesh Kanti, Patanjali coconut/amla | Price aggressor |
Naturals skin & hair (vs Banjara's) | Himalaya Wellness | Himalaya face packs, aloe gels | Pharmacy-led naturals |
Naturals skin care | Biotique, Lotus Herbals, VLCC, Patanjali | Herbal skin care | Banjara's competitive set |
Skin care (vs Nomarks) | HUL, Emami, Himalaya | Glow & Lovely, Fair & Handsome, Himalaya | Nomarks is niche |
Soaps/lotions | HUL, Wipro Consumer, Godrej Consumer, ITC | Lux, Santoor, Cinthol, Vaseline (HUL) | Almond Drops soap/lotion are small entrants |
Regional hair oils | Various (e.g., Cavinkare, Jyothy Labs) | Meera, regional oils | South India competition for Banjara's |
Peer Comparison FY2026
| Company | Market cap (INR Cr) | P/E (x) | Annual PAT (INR Cr) | EV/EBITDA (x) |
|---|---|---|---|---|
Hindustan Unilever | 428,096 | 28.6 | 15,040 | 69.6 |
Godrej Consumer Products | 86,790 | 45.4 | 1,861 | 21.5 |
Dabur India | 66,701 | 33.8 | 1,895 | 13.8 |
Colgate-Palmolive India | 48,142 | 35.7 | 1,325 | 55.0 |
Emami | 15,921 | 21.3 | 775 | 21.2 |
Jyothy Labs | 6,891 | 24.3 | 333 | 9.4 |
Bajaj Consumer Care | 6,434 | 28.9 | 190 | 18.4 |
Peer Comparison FY2026 (Annual)
| Metric | Bajaj Consumer Care FY2026 | Marico FY2025 | Dabur FY2025 | Emami FY2025 |
|---|---|---|---|---|
Revenue (INR Cr) | 1,165 | 10,831 | 12,563 | 3,809 |



